Jext (Epinephrine)

Epinephrine in Jext stimulates alpha‑ and beta‑adrenergic receptors. Alpha‑1 activation causes blood vessels to constrict, raising blood pressure and reducing swelling. Beta‑1 activation increases heart rate and contractility, while beta‑2 activation relaxes bronchial smooth muscle, producing bronchodilation and improving breathing.

The dose of Jext is determined by the prescribing healthcare professional based on the patient’s age, weight, and severity of the reaction. Only a qualified prescriber can set the appropriate dosage and administration schedule for each individual case.

Safety data for epinephrine in pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the mother or fetus. Healthcare providers will evaluate the situation and decide if treatment with Jext is appropriate.

To order Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Jext’s active ingredient, epinephrine, is the first‑line therapy for anaphylaxis and is considered the gold standard. Alternative treatments, such as antihistamines or corticosteroids, do not provide the rapid vasoconstrictive and bronchodilatory effects needed in an emergency, making epinephrine the preferred choice.

Jext should be stored at ambient temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperatures. Do not freeze the product, and check the label for the expiry date before use.

Jext is administered by intramuscular injection, typically into the outer thigh. The injection should be given promptly at the first sign of a severe allergic reaction, following the prescriber’s instructions and standard emergency protocols.

Serious risks include cardiac arrhythmias, myocardial ischemia, severe hypertension, pulmonary edema, and tissue necrosis at the injection site. Patients with underlying heart disease should be monitored closely, and any signs of severe cardiovascular complications require immediate medical attention.

Jext is contraindicated in individuals with known hypersensitivity to epinephrine or any of the product’s excipients. It should be used with caution in patients with certain cardiac conditions, uncontrolled hypertension, or those taking non‑selective beta‑blockers, and only under medical supervision.